These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36881564)

  • 1. Myeloid-specific fatty acid transport protein 4 deficiency induces a sex-dimorphic susceptibility for nonalcoholic steatohepatitis in mice fed a high-fat, high-cholesterol diet.
    Göcebe D; Jansakun C; Zhang Y; Staffer S; Tuma-Kellner S; Altamura S; Muckenthaler MU; Merle U; Herrmann T; Chamulitrat W
    Am J Physiol Gastrointest Liver Physiol; 2023 May; 324(5):G389-G403. PubMed ID: 36881564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
    Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterocyte-specific FATP4 deficiency elevates blood lipids via a shift from polar to neutral lipids in distal intestine.
    Seessle J; Liebisch G; Staffer S; Tuma-Kellner S; Merle U; Herrmann T; Chamulitrat W
    Am J Physiol Gastrointest Liver Physiol; 2024 Aug; 327(2):G202-G216. PubMed ID: 38915276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of blood lipids in hepatocyte-specific fatty acid transport 4-deficient mice fed with high glucose diets.
    Döring S; Seeßle J; Gan-Schreier H; Javaheri B; Jiao L; Cheng Y; Tuma-Kellner S; Liebisch G; Herrmann T; Stremmel W; Chamulitrat W
    Mol Genet Metab; 2019 Jan; 126(1):30-38. PubMed ID: 30497809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet.
    Kamada Y; Kiso S; Yoshida Y; Chatani N; Kizu T; Hamano M; Tsubakio M; Takemura T; Ezaki H; Hayashi N; Takehara T
    Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G1031-43. PubMed ID: 21885686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
    Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
    World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid- and hepatocyte-specific deletion of group VIA calcium-independent phospholipase A2 leads to dichotomous opposing phenotypes during MCD diet-induced NASH.
    Jansakun C; Chunglok W; Altamura S; Muckenthaler M; Staffer S; Tuma-Kellner S; Merle U; Chamulitrat W
    Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166590. PubMed ID: 36334837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
    Elife; 2023 Jan; 12():. PubMed ID: 36648330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis.
    Mauer AS; Hirsova P; Maiers JL; Shah VH; Malhi H
    Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G300-G313. PubMed ID: 28039158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model.
    Van Campenhout S; Tilleman L; Lefere S; Vandierendonck A; Raevens S; Verhelst X; Geerts A; Van Nieuwerburgh F; Van Vlierberghe H; Devisscher L
    Metabolism; 2020 Jun; 107():154220. PubMed ID: 32243868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis.
    Lee S; Usman TO; Yamauchi J; Chhetri G; Wang X; Coudriet GM; Zhu C; Gao J; McConnell R; Krantz K; Rajasundaram D; Singh S; Piganelli J; Ostrowska A; Soto-Gutierrez A; Monga SP; Singhi AD; Muzumdar R; Tsung A; Dong HH
    J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35700043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARD9 deficiency aggravated nonalcoholic steatohepatitis in mice through increasing inflammatory response.
    Liu X; Fang Y; Qian C; Chen J; Luo W; Zuo W; Lin J; Xie L; Liang G; Huang L; Wang Y
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166893. PubMed ID: 37751783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sivelestat alleviates nonalcoholic steatohepatitis in mice through inhibiting activation of Kupffer cells].
    Zang SF; Ma XJ; Wang L; Zhu GL; Yang WJ; Liu YL; Yan J; Luo Y; Zhuang ZJ; Chen JY; Xun YH; Shi JP
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):371-376. PubMed ID: 28763845
    [No Abstract]   [Full Text] [Related]  

  • 15. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
    Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
    J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Mitochondrial SAB Deletion or Knockdown Alleviates Diet-Induced Metabolic Syndrome, Steatohepatitis, and Hepatic Fibrosis.
    Win S; Min RWM; Zhang J; Kanel G; Wanken B; Chen Y; Li M; Wang Y; Suzuki A; Aung FWM; Murray SF; Aghajan M; Than TA; Kaplowitz N
    Hepatology; 2021 Dec; 74(6):3127-3145. PubMed ID: 34331779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis.
    Wang T; Sun G; Wang Y; Li S; Zhao X; Zhang C; Jin H; Tian D; Liu K; Shi W; Tian Y; Zhang D
    FASEB J; 2019 Jul; 33(7):8490-8503. PubMed ID: 30951375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
    Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
    J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.
    Leung C; Herath CB; Jia Z; Andrikopoulos S; Brown BE; Davies MJ; Rivera LR; Furness JB; Forbes JM; Angus PW
    World J Gastroenterol; 2016 Sep; 22(35):8026-40. PubMed ID: 27672297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.